FRAZIER LIFE SCIENCES MANAGEMENT, L.P. Holdings
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. is an investment fund managing more than 1.3B US dollars. The largest holdings include HilleVax, Arcutis Biotherapeutics and Phathom Pharmaceuticals. In Q3 2022 the fund bought assets of total value of 287.84M US dollars and sold assets of total value of 16.79M US dollars.
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. portfolio value:
$1.29B
portfolio value
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. quarter portfolio value change:
+11.79%
quarter
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. portfolio changes
| Period | Buy | Sel |
|---|---|---|
| Q2 2022 | 133226000 | 155464000 |
| Q3 2022 | 287835000 | 16791000 |
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. 13F holdings
| Stock |
|---|
| Portfolio share: 12.84% Portfolio value: 166.77M Avg. open price: $10.93 Current price: $17.5 P/L: +60.11% Bought +5.09% shares Q3 2022 |
| Portfolio share: 12.78% Portfolio value: 165.95M Avg. open price: $21.31 Current price: $17.35 P/L: -18.58% Bought +2.96% shares Q3 2022 |
| Portfolio share: 7.17% Portfolio value: 93.15M Avg. open price: $8.44 Current price: $11.07 P/L: +31.16% Bought +44.27% shares Q3 2022 |
| Portfolio share: 6.46% Portfolio value: 83.86M Avg. open price: $16.85 Current price: $22.77 P/L: +35.15% Bought +18.65% shares Q3 2022 |
| Portfolio share: 6.31% Portfolio value: 82.01M Avg. open price: $19.24 Current price: $25.44 P/L: +32.22% Bought +6.80% shares Q3 2022 |
| Portfolio share: 6.19% Portfolio value: 80.42M Avg. open price: $19.46 Current price: $18.33 P/L: -5.81% Bought +7.31% shares Q3 2022 |
| Portfolio share: 5.47% Portfolio value: 70.98M Avg. open price: $66.54 Current price: $75.78 P/L: +13.89% Sold -7.03% shares Q3 2022 |
| Portfolio share: 3.57% Portfolio value: 46.40M Avg. open price: N/A Current price: $27.14 P/L: N/A N/A Q3 2022 |
| Portfolio share: 3.44% Portfolio value: 44.71M Avg. open price: N/A Current price: $35.86 P/L: N/A N/A Q1 2022 |
| Portfolio share: 2.86% Portfolio value: 37.13M Avg. open price: N/A Current price: $44.33 P/L: N/A Sold -13.43% shares Q3 2022 |
| Portfolio share: 2.38% Portfolio value: 30.94M Avg. open price: N/A Current price: $12.5 P/L: N/A Sold -0.96% shares Q3 2022 |
| Portfolio share: 2.36% Portfolio value: 30.60M Avg. open price: $16.82 Current price: $16.74 P/L: -0.48% Bought +26.13% shares Q2 2022 |
| Portfolio share: 2.26% Portfolio value: 29.32M Avg. open price: N/A Current price: $8.14 P/L: N/A N/A Q3 2022 |
| Portfolio share: 2.14% Portfolio value: 27.78M Avg. open price: N/A Current price: $18.32 P/L: N/A N/A Q1 2022 |
| Portfolio share: 2.06% Portfolio value: 26.72M Avg. open price: $9.68 Current price: $0.23 P/L: -97.65% Bought +22.46% shares Q3 2022 |
| Portfolio share: 1.77% Portfolio value: 22.95M Avg. open price: N/A Current price: $28.65 P/L: N/A N/A Q1 2022 |
| Portfolio share: 1.76% Portfolio value: 22.81M Avg. open price: N/A Current price: $5.17 P/L: N/A N/A Q1 2022 |
| Portfolio share: 1.66% Portfolio value: 21.49M Avg. open price: N/A Current price: $6.78 P/L: N/A Sold -28.67% shares Q2 2022 |
| Portfolio share: 1.65% Portfolio value: 21.45M Avg. open price: N/A Current price: $13.57 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.17% Portfolio value: 15.23M Avg. open price: N/A Current price: $9.5 P/L: N/A N/A Q1 2022 |
| Portfolio share: 1.15% Portfolio value: 14.95M Avg. open price: $24.1 Current price: $14.2 P/L: -41.07% Bought +10.76% shares Q3 2022 |
| Portfolio share: 1.08% Portfolio value: 14.02M Avg. open price: N/A Current price: $15.24 P/L: N/A N/A Q3 2022 |
| Portfolio share: 1.07% Portfolio value: 13.92M Avg. open price: $16.98 Current price: $19.95 P/L: +17.49% Bought +12.49% shares Q2 2022 |
| Portfolio share: 1.04% Portfolio value: 13.46M Avg. open price: N/A Current price: $2.87 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.98% Portfolio value: 12.69M Avg. open price: $67.3 Current price: $39.53 P/L: -41.26% Bought +5.55% shares Q2 2022 |
| Portfolio share: 0.90% Portfolio value: 11.67M Avg. open price: $10.7 Current price: $6.89 P/L: -35.61% Sold -3.45% shares Q3 2022 |
| Portfolio share: 0.88% Portfolio value: 11.39M Avg. open price: N/A Current price: $42.01 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.86% Portfolio value: 11.10M Avg. open price: $30.16 Current price: $28.31 P/L: -6.14% Bought +94.30% shares Q3 2022 |
| Portfolio share: 0.76% Portfolio value: 9.85M Avg. open price: N/A Current price: $7.39 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.72% Portfolio value: 9.30M Avg. open price: N/A Current price: $2.87 P/L: N/A Sold -7.12% shares Q3 2022 |
| Portfolio share: 0.70% Portfolio value: 9.12M Avg. open price: N/A Current price: $8.01 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.67% Portfolio value: 8.69M Avg. open price: N/A Current price: $17.09 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.64% Portfolio value: 8.32M Avg. open price: $2.81 Current price: $2.09 P/L: -25.62% Bought +361.20% shares Q3 2022 |
| Portfolio share: 0.62% Portfolio value: 8.01M Avg. open price: N/A Current price: $3.22 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.49% Portfolio value: 6.42M Avg. open price: N/A Current price: $15.66 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.36% Portfolio value: 4.69M Avg. open price: N/A Current price: $1.16 P/L: N/A Sold -25.00% shares Q3 2022 |
| Portfolio share: 0.25% Portfolio value: 3.26M Avg. open price: N/A Current price: $14.36 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.19% Portfolio value: 2.42M Avg. open price: N/A Current price: $6.38 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.12% Portfolio value: 1.56M Avg. open price: N/A Current price: $1.1 P/L: N/A Sold -59.36% shares Q2 2022 |
| Portfolio share: 0.10% Portfolio value: 1.26M Avg. open price: N/A Current price: $3.47 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.08% Portfolio value: 1.03M Avg. open price: N/A Current price: $0.5 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.05% Portfolio value: 693K Avg. open price: N/A Current price: $0.25 P/L: N/A N/A Q1 2022 |
| Portfolio share: 0.00% Portfolio value: 35K Avg. open price: N/A Current price: $2.14 P/L: N/A N/A Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $21.89 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.46 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $54.99 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $26.84 P/L: N/A Sold -100.00% shares Q3 2022 |
| Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.14 P/L: N/A Sold -100.00% shares Q3 2022 |
Showing TOP 48 FRAZIER LIFE SCIENCES MANAGEMENT, L.P.'s 13F holdings.
Frequently Asked Questions (FAQ)
What is the biggest position of FRAZIER LIFE SCIENCES MANAGEMENT, L.P.?
The biggest position of the FRAZIER LIFE SCIENCES MANAGEMENT, L.P. is HilleVax, Inc. (HLVX) with 12.84% portfolio share worth of 166.77M US dollars.
Top 5 FRAZIER LIFE SCIENCES MANAGEMENT, L.P.'s holdings represent 45.56% of the portfolio:
- HilleVax, Inc. (HLVX) – 12.84%
- Arcutis Biotherapeutics, Inc. (ARQT) – 12.78%
- Phathom Pharmaceuticals, Inc. (PHAT) – 7.17%
- Chinook Therapeutics, Inc. (KDNY) – 6.46%
- Syndax Pharmaceuticals, Inc. (SNDX) – 6.31%
Who is the portfolio manager of FRAZIER LIFE SCIENCES MANAGEMENT, L.P.?
The portfolio manager of the FRAZIER LIFE SCIENCES MANAGEMENT, L.P. is .
What is the total asset value of the FRAZIER LIFE SCIENCES MANAGEMENT, L.P. portfolio?
FRAZIER LIFE SCIENCES MANAGEMENT, L.P. total asset value (portfolio value) is 1.3B US dollars.
Who is ?
is the portfolio manager of the FRAZIER LIFE SCIENCES MANAGEMENT, L.P..
What is (FRAZIER LIFE SCIENCES MANAGEMENT, L.P.) fund performance?
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.'s quarterly performance is +11.79%, annualy 0.00%.
What is the FRAZIER LIFE SCIENCES MANAGEMENT, L.P. CIK?
FRAZIER LIFE SCIENCES MANAGEMENT, L.P.'s Central Index Key is 0001892134 .